CRSP · CRISPR Therapeutics AG

Summary

CRISPR Therapeutics AG announced on March 10, 2026, that it commenced a private offering, as disclosed in a press release filed as Exhibit 99.1 with the Form 8-K. This event under Item 8.01 provides investors with information on the company's financing activities.

Key takeaways

• Company issued press release on March 10, 2026
• Commenced private offering
• Press release filed as Exhibit 99.1
• Disclosure under Item 8.01 Other Events
• Additional Exhibit 99.2 referenced